发明授权
- 专利标题： Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
-
申请号： US10333266申请日： 2001-07-19
-
公开(公告)号： US06989401B2公开(公告)日： 2006-01-24
- 发明人: Kazuhiro Maeda , Shuji Sonda , Tadahiro Takemoto , Tomokazu Goto , Fujio Kobayashi , Masahiko Kajii , Naruyasu Komorita , Fumihiro Hirayama
- 申请人： Kazuhiro Maeda , Shuji Sonda , Tadahiro Takemoto , Tomokazu Goto , Fujio Kobayashi , Masahiko Kajii , Naruyasu Komorita , Fumihiro Hirayama
- 申请人地址： JP Osaka
- 专利权人： Mitsubishi Pharma Corporation
- 当前专利权人： Mitsubishi Pharma Corporation
- 当前专利权人地址： JP Osaka
- 代理机构： Wenderoth, Lind & Ponack, L.L.P.
- 优先权： JP2000-219034 20000719; JP2000-219245 20000719
- 国际申请： PCT/JP01/06275 WO 20010719
- 国际公布： WO02/06214 WO 20020124
- 主分类号： A61K31/403
- IPC分类号： A61K31/403 ; C07D207/408
摘要：
The present invention relates to a novel sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof. More particularly, the present invention relates to a sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof, which is useful as an inhibitor of lipopolysaccharides (LPS). In addition, the present invention relates to a novel intermediate compound useful for the synthesis of this sulfonic acid derivative of hydroxamic acid.
公开/授权文献
信息查询
